Literature DB >> 19570525

Brief cognitive-behavioral internet therapy for irritable bowel syndrome.

Melissa G Hunt1, Samantha Moshier, Marina Milonova.   

Abstract

While cognitive-behavioral therapy for IBS is quite effective, the limited availability of competent therapists and lack of access to treatment remain problematic. This paper reports on a small, randomized, controlled trial of a five week internet based cognitive-behavioral intervention for IBS with limited therapist feedback via e-mail. Fifty-four IBS patients were recruited via the internet and randomly assigned to either immediate treatment or a wait-list control group. Thirty-one subjects completed the post-treatment assessment. 77% of treatment completers also completed a 3-month follow-up assessment. Treatment completers experienced statistically and clinically significant declines in IBS symptoms and improvements in quality of life. Those gains were substantially maintained at follow-up. Treatment efficacy was partially mediated by reductions in the tendency to catastrophize the social and occupational implications of symptoms, suggesting that catastrophizing may be an important target for treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19570525     DOI: 10.1016/j.brat.2009.05.002

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  36 in total

1.  Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations.

Authors:  Eric L Garland; Susan A Gaylord; Olafur Palsson; Keturah Faurot; J Douglas Mann; William E Whitehead
Journal:  J Behav Med       Date:  2011-12-08

Review 2.  Computerised cognitive behavioural therapy for psychological distress in patients with physical illnesses: a systematic review.

Authors:  Andrew McCombie; Richard Gearry; Jane Andrews; Antonina Mikocka-Walus; Roger Mulder
Journal:  J Clin Psychol Med Settings       Date:  2015-03

Review 3.  Computer-Assisted Cognitive-Behavior Therapy in Medical Care Settings.

Authors:  Jesse H Wright; Laura W McCray; Tracy D Eells; Rangaraj Gopalraj; Laura B Bishop
Journal:  Curr Psychiatry Rep       Date:  2018-09-07       Impact factor: 5.285

4.  Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study.

Authors:  Brjánn Ljótsson; Michael Jones; Nicholas J Talley; Lars Kjellström; Lars Agréus; Anna Andreasson
Journal:  United European Gastroenterol J       Date:  2020-01-14       Impact factor: 4.623

5.  Participant retention in an automated online monthly depression rescreening program: patterns and predictors.

Authors:  Supria Gill; Omar Contreras; Ricardo F Muñoz; Yan Leykin
Journal:  Internet Interv       Date:  2014-03

Review 6.  Telemedicine and Mobile Health Technology Are Effective in the Management of Digestive Diseases: A Systematic Review.

Authors:  Brian C Helsel; Joel E Williams; Kristen Lawson; Jessica Liang; Jonathan Markowitz
Journal:  Dig Dis Sci       Date:  2018-04-16       Impact factor: 3.199

Review 7.  Internet-based randomized controlled trials: a systematic review.

Authors:  Erin Mathieu; Kevin McGeechan; Alexandra Barratt; Robert Herbert
Journal:  J Am Med Inform Assoc       Date:  2012-10-13       Impact factor: 4.497

Review 8.  Effects of Self-Management Interventions in Patients With Irritable Bowel Syndrome: Systematic Review.

Authors:  Xiaomei Cong; Mallory Perry; Katherine M Bernier; Erin E Young; Angela Starkweather
Journal:  West J Nurs Res       Date:  2017-08-30       Impact factor: 1.967

9.  Comparison of long-term effects of cognitive-behavioral therapy versus mindfulness-based therapy on reduction of symptoms among patients suffering from irritable bowel syndrome.

Authors:  Saeedeh Zomorodi; Saeed Abdi; Seyed Kazem Rasulzadeh Tabatabaee
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014

Review 10.  Cognitive-behavioral therapy for the management of irritable bowel syndrome.

Authors:  Qing-Lin Tang; Guo-Yao Lin; Ming-Qing Zhang
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.